RxSight Inc.
RXST | NASDAQ
$5.14
-$0.06 (-1.15%)
At close: Sep 21, 2026, 4:00 PM ET
$5.14
$0 (0.00%)
Pre-market:
Sep 22, 2026, 9:25 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 134.48M | 139.93M | 89.08M | 49.01M | 22.59M | 14.68M |
Cost of Revenue | 31.47M | 40.98M | 35.31M | 27.68M | 18.08M | 12.97M |
Gross Profit | 103.01M | 98.94M | 53.77M | 21.33M | 4.52M | 1.71M |
Operating Income | -48.19M | -36.86M | -50.09M | -63.32M | -52.79M | -35.41M |
Interest Income | 2.51M | 9.47M | 6.57M | 1.52M | 54K | 543K |
Pretax Income | -38.88M | -27.41M | -48.59M | -66.75M | -48.68M | 27.63M |
Net Income | -38.94M | -27.46M | -48.61M | -66.76M | -48.69M | 27.58M |
Selling & General & Admin | 112.65M | 101.43M | 74.8M | 58.67M | 32.81M | 15.18M |
Research & Development | 38.55M | 34.37M | 29.05M | 25.98M | 24.5M | 21.93M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 151.2M | 135.8M | 103.85M | 84.65M | 57.3M | 37.11M |
Interest Expense | 40K | 21K | 3.31M | 4.95M | 3.68M | 510K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 182.67M | 176.79M | 139.16M | 112.32M | 75.38M | 50.08M |
Income Tax Expense | 66K | 50K | 20K | 9K | 8K | 57K |
Shares Outstanding (Basic) | 41.18M | 38.87M | 34.46M | 27.66M | 27.37M | 19.07M |
Shares Outstanding (Diluted) | 41.18M | 38.87M | 34.46M | 27.66M | 27.37M | 19.07M |
EPS (Basic) | -0.95 | -0.71 | -1.41 | -2.41 | -1.78 | 0.18 |
EPS (Diluted) | -0.95 | -0.71 | -1.41 | -2.41 | -1.78 | 0.18 |
EBITDA | -38.84M | -23.76M | -41.04M | -57.78M | -41.01M | 32.15M |
EBIT | -38.84M | -27.38M | -45.28M | -61.8M | -45M | 28.14M |
Depreciation & Amortization | n/a | 3.62M | 4.24M | 4.02M | 3.99M | 4.01M |
Add to Watchlist
Select watchlists to add or remove RXST